Assessing the Effects of Hormones on Noninvasive Transcranial Stimulation
NCT07635017 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2026-06-09
Summary
This study is investigating how two types of non-invasive brain stimulation, transcranial electrical stimulation (TES) and transcranial magnetic stimulation (TMS), affect brain activity, and whether combining them produces stronger or more consistent effects than either one used alone. The motivation for this comes from the observation that TMS, which is FDA-approved for treating depression, tends to work less well in postmenopausal women because lower estrogen levels reduce the brain's ability to respond to stimulation. The research team believes that pairing TMS with TES, which targets a different set of brain cells, may be able to overcome this hormonal barrier and make stimulation more effective. Participants will come into the lab for up to 24 visits over 8 months, beginning with an initial visit to establish the right stimulation settings, followed by a series of stimulation sessions in which brain activity is measured before and after receiving either TES, TMS, or both together. For female participants, sessions will be scheduled at specific points in the menstrual cycle to capture the natural monthly rise and fall of estrogen, while male participants will be scheduled on a comparable fixed interval as a comparison group. The insights gained from this study could directly inform the development of better, more reliable brain stimulation treatments for women with depression.
Conditions
- Cortical Excitability
- Healthy
- TMS
- Menstrual Cycle
- Menopause
Interventions
- DEVICE
-
Transcranial Electrical Stimulation
SharpFocus transcranial electrical stimulation (TES) uses a multichannel stimulator connected to a scalp electrode to deliver precisely timed, intensity-modulated electrical pulses. By varying the timing, amplitude, and location of these pulses, the system achieves focal stimulation of targeted cortical regions. Investigators will use Digitimer DS8R and/or Digitimer DS5 current stimulators to apply all current stimuli. These stimulators are CE certified and are intended for use in human research applications. The stimulator safely delivers brief duration (50-2000µs) current pulses for transcranial electrical stimulation and activation of nerves and muscles via surface electrodes. The current output of the DS8R is adjustable over the range 0mA to 1000mA, with a compliance voltage of up to 400V and an energy limit of 300mJ.
- DEVICE
-
Transcranial Magnetic Stimulation
Transcranial magnetic stimulation (TMS) uses an electromagnetic coil placed over the scalp to deliver precisely timed magnetic pulses that induce electric fields in targeted cortical regions. By varying the frequency, intensity, and coil position, the system achieves non-invasive stimulation of specific brain areas. Investigators will use the DuoMag XT-100 rTMS system manufactured by DEYMED Diagnostic. The device is a CE-certified Class IIa medical device intended for use in human research and clinical applications. The DuoMag XT-100 delivers both monophasic and biphasic pulses with a total pulse duration of 290 µs and a maximum discharge energy of 265 J, capable of stimulating at 100% intensity at 22 Hz and up to 100 Hz at less than 50% intensity.
- DEVICE
-
TES + TMS
The combined TMS+TES intervention delivers concurrent transcranial magnetic and electrical stimulation using the DuoMag XT-100 rTMS system and the Digitimer DS8R/DS5 current stimulators simultaneously. The DuoMag XT-100 is a CE-certified Class IIa device manufactured by DEYMED Diagnostic, delivering monophasic and biphasic pulses with a 290 µs pulse duration and 265 J maximum discharge energy, capable of 100% intensity at 22 Hz and up to 100 Hz at less than 50% intensity. The Digitimer DS8R/DS5 are CE-certified stimulators delivering brief duration (50-2000 µs) current pulses via surface electrodes, with current output adjustable from 0mA to 1000mA, compliance voltage up to 400V, and energy limit of 300mJ. Standard adhesive electrodes are replaced with Soterix Sintered Ag/AgCl ring electrodes featuring radial slits to impede induced eddy currents. Magnetic pulses are delivered via the DuoMag 70BF liquid-cooled butterfly coil. Pulses are interleaved with a 1-3 ms latency.
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-07-01
- Primary Completion
- 2028-05-01
- Completion
- 2028-07-01
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Safety and Efficacy Study of Deep Transcranial Magnetic Stimulation in Bipolar Depression
NCT01566591 ·Status: UNKNOWN ·Phase: NA
-
Testing a Transdiagnostic TMS Treatment Target
NCT06282146 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Brain Oscillation-synchronized Stimulation of the Frontal Cortex in Major Depressive Disorder
NCT06345651 ·Status: RECRUITING ·Phase: NA
-
Brain-derived Neurotrophic Factor and the Antidepressant Efficacy of Brain Stimulation
NCT04076124 ·Status: UNKNOWN ·Phase: NA
-
Concurrent fMRI-guided rTMS and Cognitive Therapy for the Treatment of Major Depressive Episodes
NCT03289923 ·Status: COMPLETED ·Phase: NA
-
Brain-oscillation Synchronised Stimulation of the Prefrontal Cortex
NCT02920840 ·Status: COMPLETED ·Phase: NA
-
Transcranial Magnetic Stimulation in Depression
NCT00018746 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Clustered Versus Tapered Repetitive Transcranial Magnetic Stimulation (rTMS) as Maintenance Therapy Following Successful Acute rTMS Treatment in Patients With Depressive Syndrome
NCT07727005 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
rTMS for PTSD Comorbid With Major Depressive Disorder
NCT02273063 ·Status: COMPLETED ·Phase: NA
-
Establishing a Dose-response Relationship With Accelerated Transcranial Magnetic Stimulation
NCT04243798 ·Status: COMPLETED ·Phase: NA
-
Transcranial Photobiomodulation (tPBM) for Somatic Symptoms in Treatment-Resistant Depression
NCT07543328 ·Status: RECRUITING ·Phase: NA
-
Mini Theta Burst TMS in MDD Patients
NCT04014959 ·Status: COMPLETED ·Phase: NA
-
Repetitive Transcranial Magnetic Stimulation for Adolescent Depression: Efficacy, Predictive Biomarkers, and Mechanisms
NCT02611206 ·Status: COMPLETED ·Phase: NA
-
Individualized Functional Connectivity Targeting in aiTBS for Depression
NCT05680727 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Transcranial Magnetic Stimulation of the Default Mode Network to Improve Sleep - Clinical Trial
NCT06631209 ·Status: RECRUITING ·Phase: NA
-
The Effect of Transcranial Magnetic Stimulation Treatment on Microvasculature Stracture of the Retina and the Choroid
NCT06708013 ·Status: COMPLETED ·Phase: NA
-
Effects of Low-intensity Transcranial Magnetic Stimulation on Major Depressive Disorder, and on 5-hydroxyindoleacetic Acid and Brain-derived Neurotrophic Factor Levels
NCT06667180 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy and Safety Assessment of Temporal Interference Stimulation to Improve Bipolar Depression
NCT07021508 ·Status: RECRUITING ·Phase: NA
-
Intensive TMS for Bipolar Depression
NCT05228457 ·Status: COMPLETED ·Phase: NA
-
TMS Treatment for Depression in the National Health Service
NCT02016456 ·Status: COMPLETED ·Phase: NA
-
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
NCT01370733 ·Status: COMPLETED ·Phase: PHASE3
-
Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
NCT06376734 ·Status: RECRUITING ·Phase: PHASE2
-
Transcranial Magnetic Stimulation in Depression.
NCT07638202 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Accelerated Intermittent Theta-burst Stimulation (a-iTBS) in Adolescents With Depressive Disorder
NCT07369713 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Symptom-specific TMS Targets for Depression and Anxiety
NCT04604210 ·Status: COMPLETED ·Phase: PHASE2